An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Sanofi’s Tzield Approved in the U.S. for Patients with Stage 3 Type 1 Diabetes On June 13, Sanofi announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Tzield (teplizumab-mzwv) to delay the decline in endogenous (own)...
While all of ENDO 2026 sessions are can’t miss events, certain ones almost always inspire certain passions among the attendees, and those are the debates! Former Endocrine Society president Stephen Hammes, MD, PhD, moderated the Endocrine Debate session “Low Testosterone in Obesity: Should We Treat or Not?” and Kelly Horvath has taken a deep dive...
Endocrine Society members share highlights and cherished memories from past annual conferences. Since ENDO 2026 in Chicago is fresh in our minds, Endocrine News quizzed Endocrine Society members to see what their favorite memories of past ENDOs have been. From professional connections to new job leads, lifelong friendships, and even some unforgettable meals, ENDO is...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in CAH at ENDO 2026 On June 14, Crinetics Pharmaceuticals, Inc. presented data from the open-label, Phase 2 congenital adrenal hyperplasia (CAH) adult study of investigational atumelnant, a novel, once-daily oral...
Nanette Santoro, MD, knew she wanted to be a doctor at age 16, feeling like it was the best way to help people, something that would be good for mankind. The Endocrine Society is pleased to welcome Santoro, of the University of Colorado School of Medicine in Aurora, Colo., as its 2026 – 2027 president....
During ENDO 2026 in Chicago, the Endocrine Society will release its latest treatment recommendations, “Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline.” Attendees are encouraged to arrive early at Room W375C at McCormick Place on Saturday June 13 at 4:30 p.m., for this highly anticipated session. At ENDO 2025 in San Francisco, researchers...
Some subgroups of children with precocious puberty — such as older girls with slowly progressing puberty—may not need the same level of testing or treatment, according to a new Endocrine Society Clinical Practice Guideline released today. “Children who start puberty earlier than usual should be carefully evaluated so they receive the right care at the right time—without...
Discover the latest advances in hormone research and clinical endocrinology at ENDO 2026. This year’s conference, taking place in Chicago, Ill., June 13-16, 2026, is designed to enhance your knowledge and skills in endocrinology with a mix of programs for both the clinician and researcher. With an extensive program covering a broad array of topics,...